An estimated combined total of 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2021. New cases of leukemia, lymphoma and myeloma are expected to account for 9.8 percent of the estimated 1,898,160 new cancer cases that will be diagnosed in the US in 2021.